Entities / Company
CalciMedica (United States).
company in La Jolla, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 16
What's happening
Gone quiet
No new reports in 90+ days-
CalciMedica's lead candidate, Auxora, showed promising protective effects in AKI, with trial rationale published in the American Journal of Nephrology.Speculative1 report
-
CalciMedica, led by CEO Rachel Leheny, is scheduled to present at the H.C. Wainwright conference on September 2, 2025.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around CalciMedica (United States) this week
News at the entities that move CalciMedica (United States) most-
FDA StructuralCRISPR Therapeutics and Vertex Pharmaceuticals received FDA approval for their gene therapy Casgevy for sickle cell disease.Moves CalciMedica (United States)
Connections
The 1 strongest of 16, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
CalciMedica engages with the FDA regarding regulatory planning for its Phase 3 program.